Listar Unidade de investigación en Enfermidades Infecciosas: Hepatite e SIDA por autor "López-Calvo, Soledad"
Mostrando ítems 1-3 de 3
-
Hemorragia digestiva alta secundaria a sarcoma de Kaposi gástrico y duodenal
Bello, Laura; Pardeiro Pértega, Remedios; Couto Wörner, Ignacio; Vázquez Rodríguez, Pilar; López-Calvo, Soledad; Castro-Iglesias, Ángeles; Mena, Álvaro; Alonso Aguirre, Pedro; Pedreira, José D. (Sociedad Española de Patología Digestiva, 2012) -
Total HCV core antigen assay: a new marker of HCV viremia and its application during treatment of chronic hepatitis C
Lorenzo, José; Castro-Iglesias, Ángeles; Aguilera, Antonio; Prieto, Elizabeth; López-Calvo, Soledad; Regueiro, Benito; Pedreira, José D. (Elsevier, 2004-06-15)[Abstract] The present study assesses the clinical usefulness of the hepatitis C core antigen assay for monitoring of patients being treated for chronic hepatitis C virus (HCV) infection. Eighty-six serum samples were ... -
Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV‐infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine
Cid-Silva, Purificación; Fernández-Bargiela, Noelia; Margusino-Framiñán, Luis; Balboa-Barreiro, Vanesa; Mena, Álvaro; López-Calvo, Soledad; Vázquez-Rodríguez, Pilar; Martín-Herranz, Isabel; Míguez-Rey, Martín; Poveda, Eva; Castro-Iglesias, Ángeles (Wiley, 2018-11-02)[Abstract] Two elvitegravir/cobicistat‐based therapies combined with emtricitabine/tenofovir disoproxil fumarate (EVG/c/FTC/TDF) or emtricitabine/tenofovir alafenamide fumarate (EVG/c/FTC/TAF) are currently available for ...